Term Sheet

The latest on private equity, M&A, deals and movements — from Wall Street to Silicon Valley

Pre-Marketing: Nestlé gets Pfizer baby biz

April 23, 2012: 7:00 AM ET

* 60 Minutes: The case against Lehman Brothers

* Ken Auletta: Too few walls between Stanford and Silicon Valley?

* Great Wolf fallout: Shortcomings of banker valuation opinions

* Felix Salmon: What does corruption scandal mean for Banco Walmart?

* Cocoa-flavored formula: Nestlé buying Pfizer's infant biz for $11.9 billion

* Morning Call: U.S. futures point lower, European shares fall and the Nikkei retreats.

* Charlie O'Donnell: When should I raise my seed round?

* Ben Horowitz: About our Instagram & PicPlz investments

* Greg Roth: Georgia is finally on private equity's mind

* Pay to play? Wall St. worried about big Romney donations

* Get Term Sheet: Sign up for our daily email on deals & deal-makers

* Merger Monday: Vodafone buying Cable & WirelessAstraZeneca buying Ardea

Posted in:
Join the Conversation
About This Author
Dan Primack
Dan Primack
Senior Editor, Fortune

Dan Primack joined Fortune.com in September 2010 to cover deals and dealmakers, from Wall Street to Sand Hill Road. Previously, Dan was an editor-at-large with Thomson Reuters, where he launched both peHUB.com and the peHUB Wire email service. In a past journalistic life, Dan ran a community paper in Roxbury, Massachusetts. He currently lives just outside of Boston.

Email a Tip | @danprimack | RSS
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Powered by WordPress.com VIP.